Transmission and spreading of tauopathy in transgenic mouse brain

Cited by (1,006)

Items 401–500 of 1,006

1. Role of Microglial Cells in Alzheimer’s Disease Tau Propagation
   Ena Španić, Lea Langer Horvat, Patrick R. Hof, Goran Šimić · 2019 · Frontiers in Aging Neuroscience
2. Molecular analysis and biochemical classification of TDP-43 proteinopathy
   Hiroshi Tsuji, Tetsuaki Arai, Fuyuki Kametani, Takashi Nonaka, Makiko Yamashita, Masami Masuda‐Suzukake, Masato Hosokawa, Mari Yoshida, Hiroyuki Hatsuta, Masaki Takao et al. · 2012 · Brain
3. Extracellular Vesicle Biology in Alzheimer’s Disease and Related Tauopathy
   Annina M. DeLeo, Tsuneya Ikezu · 2017 · Journal of Neuroimmune Pharmacology
4. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
   Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, Keqiang Ye · 2024 · Translational Neurodegeneration
5. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity
   Ando, Kanae, Maruko-Otake, Akiko, Ohtake, Yosuke, Hayashishita, Motoki, Sekiya, Michiko, Iijima, Koichi M. · 2016 · PLOS Genetics
6. Prions and the Potential Transmissibility of Protein Misfolding Diseases
   Allison Kraus, Bradley R. Groveman, Byron W. Caughey · 2013 · Annual Review of Microbiology
7. Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy
   Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno Pietro Imbimbo, Madia Lozupone, Andrea Santamato, Rosanna Tortelli, Ilaria Galizia, Camilla Prete, Antonio Daniele et al. · 2016 · Immunotherapy
8. Tau interactome and RNA binding proteins in neurodegenerative diseases
   Tomas Kavanagh, Aditi Halder, Eleanor Drummond · 2022 · Molecular Neurodegeneration
9. Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
   Allal Boutajangout, Thomas Wısnıewskı · 2014 · Gerontology
10. Mouse Models for Studying the Formation and Propagation of Prions
    Joel C. Watts, Stanley B. Prusiner · 2014 · Journal of Biological Chemistry
11. Variations in filament conformation dictate seeding barrier between three- and four-repeat Tau
    Dinkel, Paul D., Siddiqua, Ayisha, Huynh, Huy, Shah, Monil, Margittai, Martin · 2011 · Biochemistry
12. Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration
    Christiane Richter‐Landsberg, Janina Leyk · 2013 · Acta Neuropathologica
13. Can Parkinson's disease pathology be propagated from one neuron to another?
    Christopher J.R. Dunning, Juan F. Reyes, Jennifer A. Steiner, Patrik Brundin · 2011 · Progress in Neurobiology
14. Truncation of Tau selectively facilitates its pathological activities
    Jianlan Gu, Wen Xu, Nana Jin, Longfei Li, Yan Zhou, Dandan Chu, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2020 · Journal of Biological Chemistry
15. Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
    Huiqin Zhang, Yu Cao, Lina Ma, Yun Wei, Hao Li · 2021 · Frontiers in Cell and Developmental Biology
16. Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity
    Wataru Kudo, Lee Hp, Mark A. Smith, Xiongwei Zhu, S Matsuyama, H-g Lee · 2012 · Cell Death and Disease
17. Brain injury, neuroinflammation and Alzheimer's disease
    Joshua J. Breunig, Marie‐Victoire Guillot‐Sestier, Terrence Town · 2013 · Frontiers in Aging Neuroscience
18. Tau physiology and pathomechanisms in frontotemporal lobar degeneration
    Bodea, Liviu‐Gabriel, Eckert, Anne, Ittner, Lars Matthias, Piguet, Olivier, Götz, Jürgen · 2016 · Journal of Neurochemistry
19. Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress
    Rudy J. Castellani, George L. Perry · 2012 · Archives of Medical Research
20. Alzheimer's disease: Pathogenesis and prevention
    Heiko Braak, Kelly Del Tredici · 2012 · Alzheimer s & Dementia
21. Pathological Changes of Tau Related to Alzheimer’s Disease
    Dandan Chu, Fei Liu · 2018 · ACS Chemical Neuroscience
22. Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143—Further Implications for Alzheimer's Therapy
    Anna Chiarini, Ubaldo Armato, Emanuela Gardenal, Li Gui, Ilaria Dal Prà · 2017 · Frontiers in Neuroscience
23. Dissecting the potential molecular mechanisms underlying α-synuclein cell-to-cell transfer in Parkinson's disease
    Élodie Angot, Patrik Brundin · 2009 · Parkinsonism & Related Disorders
24. Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective
    François Le Guerroué, Richard J. Youle · 2020 · Cell Death and Differentiation
25. Prion-like Spreading in Tauopathies
    Jacob I. Ayers, Benoit I. Giasson, David Borchelt · 2017 · Biological Psychiatry
26. TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer’s disease
    Melanie B. Shulman, Jessica Kong, John T. O'Gorman, Elena Ratti, Raj Rajagovindan, Louis Viollet, Ellen Huang, Sanjiv Sharma, Annie Marie Racine, Julie Czerkowicz et al. · 2023 · Nature Aging
27. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
    Dai, Chun-ling, Hu, Wen, Tung, Yunn Chyn, Liu, Fei, Gong, Cheng-Xin, Iqbal, Khalid · 2018 · Alzheimer's Research & Therapy
28. Immunotherapy for Alzheimer's disease
    Thomas Wısnıewskı, Fernando Goñi · 2014 · Biochemical Pharmacology
29. Tau Overexpression Results in Its Secretion via Membrane Vesicles
    Diana Simón, Esther García‐García, Alberto Gómez‐Ramos, Juan Manuel Falcón‐Pérez, Miguel Dı́az-Hernández, Félix Hernández, Jesús Ávila · 2012 · Neurodegenerative Diseases
30. Peptides, Peptidomimetics, and Carbohydrate–Peptide Conjugates as Amyloidogenic Aggregation Inhibitors for Alzheimer’s Disease
    Philip Ryan, Bhautikkumar Patel, Vivek Makwana, Hemant R. Jadhav, Milton J. Kiefel, Andrew Keith Davey, Tristan A. Reekie, Santosh Rudrawar, Michael Kassiou · 2018 · ACS Chemical Neuroscience
31. TIA1 regulates the generation and response to toxic tau oligomers
    Lulu Jiang, Peter E.A. Ash, Brandon F. Maziuk, Heather I. Ballance, Samantha Boudeau, Ali Al Abdullatif, Marcello Orlando, Leonard Petrucelli, Tsuneya Ikezu, Benjamin L. Wolozin · 2018 · Acta Neuropathologica
32. Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy
    Marie‐Laure Caillet‐Boudin, Francisco-José Fernández-Gómez, Hélène Tran, Claire‐Marie Dhaenens, Luc Buée, Nicolas Sergeant · 2014 · Frontiers in Molecular Neuroscience
33. Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology
    Ahnaou, A., Moechars, D., Raeymaekers, L., Biermans, R., Manyakov, N. V., Bottelbergs, A., Wintmolders, C., Van Kolen, K., Van De Casteele, T., Kemp, J. A. et al. · 2017 · Scientific Reports
34. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice
    Baker, Siân, Polanco, Juan Carlos, Götz, Jϋrgen · 2016 · Journal of Alzheimer's Disease
35. Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
    Hanger, Diane P, Seereeram, Anjan, Noble, Wendy · 2009 · Expert Review of Neurotherapeutics
36. Longitudinal Alzheimer’s Degeneration Reflects the Spatial Topography of Cholinergic Basal Forebrain Projections
    Taylor W. Schmitz, Marieke Mur, Meghmik Aghourian, Marc‐André Bédard, R. Nathan Spreng · 2018 · Cell Reports
37. Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition
    Lorena Saelices, Kevin Chung, Ji Hun Lee, Whitaker Cohn, Julian P. Whitelegge, Merrill D. Benson, David S Eisenberg · 2018 · Proceedings of the National Academy of Sciences
38. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission
    Ann Van der Jeugd, Tariq Ahmed, Sylvie Burnouf, Karim Bélarbi, Malika Hamdame, Marie‐Eve Grosjean, Sandrine Humez, Detlef Balschun, David L Blum, Luc Buée et al. · 2010 · Neurobiology of Learning and Memory
39. Tau as a Therapeutic Target for Alzheimers Disease
    Allal Boutajangout, Einar M. Sigurdsson, P. K. Krishnamurthy · 2011 · Current Alzheimer Research
40. Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death
    Mengyu Liu, Dexin Sui, Thomas Steven Dexheimer, Stacy Hovde, Xiexiong Deng, Kuang‐Wei Wang, Hsin Lian Lin, Hsiao‐Tien Chien Hagar, Hye Kyong Kweon, Nora Sheen Kuo et al. · 2020 · Molecular Neurobiology
41. Hsc70 Rapidly Engages Tau after Microtubule Destabilization
    Umesh K. Jinwal, John C. O’Leary, Sergiy I. Borysov, Jeffrey R. Jones, Qingyou Li, John Koren, Jose Francisco Abisambra, Grant D. Vestal, Lisa Y. Lawson, Amelia G. Johnson et al. · 2010 · Journal of Biological Chemistry
42. Mouse models of frontotemporal dementia
    Erik D. Roberson · 2012 · Annals of Neurology
43. The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
    Michael S. Wolfe · 2012 · Scientifica
44. Current Status of Clinical Trials on Tau Immunotherapies
    Ji, Changyi, Sigurdsson, Einar M. · 2021 · Drugs
45. The mechanism of Hsp90-induced oligomerizaton of Tau
    Sabrina Weickert, Magdalena Wawrzyniuk, Laura John, Stefan Rüdiger, Malte Drescher · 2020 · Science Advances
46. What Makes a Protein Sequence a Prion?
    Raimon Sabaté, Frédéric Rousseau, Joost W. H. Schymkowitz, Salvador Ventura · 2015 · PLoS Computational Biology
47. Review: Prion‐like mechanisms of transactive response DNA binding protein of 43 kDa ( TDP ‐43) in amyotrophic lateral sclerosis ( ALS )
    Phillip Smethurst, Katie C. L. Sidle, John Hardy · 2014 · Neuropathology and Applied Neurobiology
48. Is Alzheimer’s disease an inflammasomopathy?
    Cláudia Pereira, Armanda E. Santos, Paula Isabel Moreira, Ana Catarina Pereira, Fábio J. Sousa, Sandra M. Cardoso, Maria Teresa Cruz · 2019 · Ageing Research Reviews
49. Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies
    Thomas Vogels, Antoine Leuzy, Claudia Cicognola, Nicholas James Ashton, Tomáš Smolek, Michal Novák, Kaj Blennow, Henrik Zetterberg, Tomáš Hromádka, Norbert Žilka et al. · 2019 · Biological Psychiatry
50. Tau oligomers derived from traumatic brain injury cause cognitive impairment and accelerate onset of pathology in htau mice
    Gerson, Julia, Castillo-Carranza, Diana L., Sengupta, Urmi, Bodani, Riddhi, Prough, Donald S., DeWitt, Douglas S., Hawkins, Bridget E., Kayed, Rakez · 2016 · Journal of Neurotrauma
51. Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex
    Wang, Peng, Ye, Yihong · 2021 · Nature Communications
52. In vivo imaging of tau pathology using multi-parametric quantitative MRI
    Wells, J.A., O'Callaghan, J.M., Holmes, H.E., Powell, N.M., Johnson, R.A., Siow, B., Torrealdea, F., Ismail, O., Walker-Samuel, S., Golay, X. et al. · 2015 · NeuroImage
53. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
    Yanuar Alan Sulistio, Klaus Heese · 2015 · Molecular Neurobiology
54. Clinical Approach to Progressive Supranuclear Palsy
    Helen Ling · 2016 · Journal of Movement Disorders
55. The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s Disease
    Brittany N. Dugger, Charisse M. Whiteside, Chera L. Maarouf, Douglas G. Walker, Thomas G. Beach, Lucia I. Sue, Angelica Garcia, Travis L. Dunckley, Bessie Meechoovet, Eric M. Reiman et al. · 2016 · Journal of Alzheimer s Disease
56. New Features about Tau Function and Dysfunction
    Miguel Medina, Félix Hernández, Jesús Ávila · 2016 · Biomolecules
57. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease
    Wei Liu, Jingya Zhao, Guangxiu Lu · 2016 · Biochemical and Biophysical Research Communications
58. Age-related diseases as vicious cycles
    Aleksey V. Belikov · 2018 · Ageing Research Reviews
59. Hyperphosphorylated tau in young and middle-aged subjects
    Adila El‐Obeid, Hilkka S. Soininen, Irina I. Alafuzoff · 2011 · Acta Neuropathologica
60. Structural Typing of Systemic Amyloidoses by Luminescent-Conjugated Polymer Spectroscopy
    K. Peter R. Nilsson, Kristian Ikenberg, Andreas Åslund, Sophia Fransson, Peter Konradsson, Christoph Röcken, Holger Moch, Adriano Aguzzi · 2009 · American Journal Of Pathology
61. Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
    Valeria Melis, Mandy Magbagbeolu, Janet E. Rickard, David Horsley, Kathleen Davidson, Kathleen A. Harrington, Keith A. Goatman, Elizabeth A. Goatman, Serena Deiana, Steve Close et al. · 2015 · Behavioural Pharmacology
62. Tau, prions and Aβ: the triad of neurodegeneration
    Lilla Reiniger, Ana Lukić, Jacqueline M. Linehan, Peter Rudge, John Collinge, Simon Mead, Sebastian Brandner · 2010 · Acta Neuropathologica
63. Alzheimer's Disease-like Paired Helical Filament Assembly from Truncated Tau Protein Is Independent of Disulfide Crosslinking
    Youssra K. Al‐Hilaly, Saskia J. Pollack, Devkee M. Vadukul, Francesca Citossi, Janet E. Rickard, Michael C. Simpson, John M. D. Storey, Charles R. Harrington, Claude M. Wischik, Louise C. Serpell · 2017 · Journal of Molecular Biology
64. Targeting tau: clinical trials and novel therapeutic approaches
    VandeVrede, Lawren, Boxer, Adam L., Polydoro, Manuela · 2020 · Neuroscience Letters
65. Tau immunotherapies: Lessons learned, current status and future considerations
    Sandusky-Beltran, L.A., Sigurdsson, E.M. · 2020 · Neuropharmacology
66. Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau
    Muneaki Takahashi, Haruka Miyata, Fuyuki Kametani, Takashi Nonaka, Haruhiko Akiyama, Shin‐ichi Hisanaga, Masato Hasegawa · 2015 · Acta Neuropathologica
67. Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies
    Chun‐Ling Dai, Xia Chen, Syed Faraz Kazim, Fei Liu, Cheng‐Xin Gong, Inge Grundke, Khalid Iqbal · 2014 · Journal of Neural Transmission
68. Prions and Protein Assemblies that Convey Biological Information in Health and Disease
    David W. Sanders, Sarah K. Kaufman, Brandon B. Holmes, Marc I. Diamond · 2016 · Neuron
69. Frontal Cortex Neuropathology in Dementia Pugilistica
    Tommy Saing, Malcolm B. Dick, Peter T. Nelson, Ronald C. Kim, David H. Cribbs, Elizabeth Head · 2011 · Journal of Neurotrauma
70. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
    Pritchard, Susanne M., Dolan, Philip J., Vitkus, Alisa, Johnson, Gail V.W. · 2011 · Journal of Cellular and Molecular Medicine
71. Neuropathology of iatrogenic Creutzfeldt–Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology
    Charles J. Duyckaerts, Véronique Sazdovitch, Kunié Ando, Danielle Seilhean, Nicolas Privat, Zehra Yilmaz, Laurène Peckeu, Élodie Bouaziz-Amar, Emmanuel E. Comoy, Aleksandra Maleska Maceski et al. · 2017 · Acta Neuropathologica
72. Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease
    Jane Ann Driver, Xiao Zhen Zhou, Kun Ping Lu · 2015 · Biochimica et Biophysica Acta (BBA) - General Subjects
73. AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice
    Tomasz Jaworski, Ilse Dewachter, Benoit Lechat, Sophie Croes, Annelies Termont, David Demedts, Peter Borghgraef, Herman Devijver, Robert Kuba Filipkowski, Leszek Kaczmarek et al. · 2009 · PLoS ONE
74. Transmission of Systemic AA Amyloidosis in Animals
    Tomoaki Murakami, Naotaka Ishiguro, Keiichi Higuchi · 2013 · Veterinary Pathology
75. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis
    Elaheh Ekhtiari Bidhendi, Johan Bergh, Per Zetterström, Karin Forsberg, Bente Pakkenberg, Peter Munch Andersen, Stefan L. Marklund, Thomas Brännström · 2018 · Acta Neuropathologica
76. Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology
    Vera I. Wiersma, Anna Maria van Ziel, Sonia Vazquez‐Sanchez, Anna Nölle, Ernesto Berenjeno‐Correa, Anna Bonaterra‐Pastra, Florence Clavaguera, Markus Tolnay, René J.P. Musters, Jan R.T. van Weering et al. · 2019 · Acta Neuropathologica
77. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic
    Simon Dujardin, Morvane Colin, Luc Buée · 2014 · Neuropathology and Applied Neurobiology
78. Emerging Therapeutics for Alzheimer's Disease
    Karen Chiang, Edward H. Koo · 2014 · The Annual Review of Pharmacology and Toxicology
79. Metabolic Dysfunction in Alzheimer’s Disease: From Basic Neurobiology to Clinical Approaches
    Julia Rosauro Clarke, Felipe Campos Ribeiro, Rudimar Luiz Frozza, Fernanda G. De Felice, Mychael V. Lourenco · 2018 · Journal of Alzheimer s Disease
80. Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
    Novak, Petr, Kontsekova, Eva, Zilka, Norbert, Novak, Michal · 2018 · Frontiers in Neuroscience
81. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
    M. Catarina Silva, Stephen J. Haggarty · 2020 · International Journal of Molecular Sciences
82. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage
    Yohei Shibuya, Zhaoyang Niu, Elena Y. Bryleva, Brent T. Harris, Stephanie R Murphy, Alireza Kheirollah, Zachary D. Bowen, Catherine C.Y. Chang, Ta‐Yuan Chang · 2015 · Neurobiology of Aging
83. Conformational Features of Tau Fibrils from Alzheimer’s Disease Brain Are Faithfully Propagated by Unmodified Recombinant Protein
    Olga A. Morozova, Zachary M. March, Anne Skaja Robinson, David W. Colby · 2013 · Biochemistry
84. Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism
    Abhisek Mukherjee, Diego Morales‐Scheihing, Natalia Salvadores, Inés Moreno‐González, César González, Kathleen Taylor-Presse, Nicolás Méndez, Mohammad Shahnawaz, Ahmed Osama Gaber, Omaima M. Sabek et al. · 2017 · The Journal of Experimental Medicine
85. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
    Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin · 2023 · Drug Discovery Today
86. Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity
    Satish Kumar, Katharina Tepper, Senthilvelrajan Kaniyappan, Jacek Biernat, Susanne Wegmann, Eva‐Maria Mandelkow, Daniel J. Müller, Eckhard Mandelkow� · 2014 · Journal of Biological Chemistry
87. Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons
    Nguyen‐Vi Mohamed, Vanessa Plouffe, Gaudeline Rémillard‐Labrosse, Emmanuel Planel, Nicole M. Leclerc · 2014 · Scientific Reports
88. Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-Terminal Domain of Apolipoprotein E
    Leroy, Arnaud, Landrieu, Isabelle, Huvent, Isabelle, Legrand, Dominique, Codeville, Bernadette, Wieruszeski, Jean-Michel, Lippens, Guy · 2010 · Journal of Biological Chemistry
89. α-Synuclein-carrying extracellular vesicles in Parkinson’s disease: deadly transmitters
    Dimitry A. Chistiakov, Alexander A. Chistiakov · 2016 · Acta Neurologica Belgica
90. Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memory
    Mark Halliday, Giovanna R. Mallucci · 2014 · Neuropathology and Applied Neurobiology
91. The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
    Dietmar Rudolf Thal, Sandra O. Tomé · 2022 · Brain Research Bulletin
92. Exosomes-associated neurodegeneration and progression of Parkinson's disease.
    Isabella Russo, Luigi Bubacco, Elisa Greggio · 2012 · Europe PMC (PubMed Central)
93. The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
    Rozpędek-Kamińska, Wioletta, Siwecka, Natalia, Wawrzynkiewicz, Adam, Wojtczak, Radosław, Pytel, Dariusz, Diehl, J. Alan, Majsterek, Ireneusz · 2020 · International Journal of Molecular Sciences
94. Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
    Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2017 · Journal of Alzheimer s Disease
95. Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data
    Kirsten I. Taylor, Fabio Sambataro, Frank Boess, Alessandro Bertolino, Juergen Dukart · 2018 · Frontiers in Aging Neuroscience
96. Sleep-Wake Cycle in Alzheimer’s Disease Is Associated with Tau Pathology and Orexin Dysregulation
    Claudio Liguori, Matteo Spanetta, Francesca Izzi, Flaminia Franchini, Marzia Nuccetelli, Giulia Maria Sancesario, Simona Gabriella Di Santo, Sergio Bernardini, Nicola Biagio Mercuri, Fabio Placidi · 2020 · Journal of Alzheimer s Disease
97. Extracellular Tau and Its Potential Role in the Propagation of Tau Pathology
    Kaoru Yamada · 2017 · Frontiers in Neuroscience
98. Tau prion-like propagation: state of the art and current challenges
    Dujardin, Simon, Hyman, Bradley T. · 2019 · Advances in Experimental Medicine and Biology
99. Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models
    Aamir S. Mukadam, Lauren V. C. Miller, Annabel E. Smith, Marina Vaysburd, Siri Aastedatter Sakya, Sophie Sanford, Sophie Keeling, Benjamin J. Tuck, Taxiarchis Katsinelos, Christopher Green et al. · 2023 · Science
100. Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules
     Cecilia Anna Brunello, Xu Yan, Henri J. Huttunen · 2016 · Scientific Reports